Advertisement

Updated January 14th, 2021 at 09:12 IST

Indonesian health workers receive COVID-19 vaccination

The Health Ministry is planning to vaccinate more than 1.3 million health workers and 17.4 million public officials in the first stage. Indonesia, the world’s fourth most populous country, plans to vaccinate two-thirds of its population of about 270 million people — or just over 180 million people.

| Image:self
Advertisement

Indonesia started vaccinating health workers and public servants for COVID-19 on Thursday, a day after President Joko Widodo received the first shot of China’s Sinovac Biotech vaccine.

The Health Ministry is planning to vaccinate more than 1.3 million health workers and 17.4 million public officials in the first stage. Indonesia, the world’s fourth most populous country, plans to vaccinate two-thirds of its population of about 270 million people — or just over 180 million people.

“The pandemic is still going on and health care workers are the front-liners in caring for COVID-19 patients,” Deputy Health Minister Dante Saksono said. The first 25 health workers to get the jab were employees of Jakarta's Cipto Mangunkusumo Hospital. Hospital Director Lies Dina Liastuti said a total of 6,000 will be vaccinated at a rate of 275 a day.

Indonesia’s Food and Drug Authority green-lighted emergency use authorization of the vaccine produced by China's Sinovac Biotech Ltd., after the country's highest Islamic body last week said the shot is fit for consumption by Muslims. Indonesia is the world's most populous Muslim nation.

The Health Ministry expects it will take 15 months for Indonesia to complete the vaccination program, through March 2022.

The rollout comes as Indonesia registered the daily record in COVID-19 infections and fatalities on Wednesday, with 11,278 cases and 306 deaths in the last 24 hours. The country has recorded more than 858,000 infections and over 24,900 deaths in total.

Some scientists warn that not enough data has been published about the effectiveness or safety of the Sinovac vaccine — and there is uncertainty over just how protective it is. It has yet to be tested in tens of thousands of people in the kind of rigorous study considered necessary before being licensed for wide use.

Researchers in Brazil last week had pegged the vaccine as 78% effective at protecting against symptomatic illness — but this week, after a closer look at mild cases, they announced data showing overall, effectiveness is just over 50%.

Advertisement

Published January 14th, 2021 at 09:12 IST

Your Voice. Now Direct.

Send us your views, we’ll publish them. This section is moderated.

Advertisement
Advertisement

Trending Quicks

Congress Press Conference
a few seconds ago
Kerala Nirmal Lottery Sambad Friday Result
a few seconds ago
Virat Kohli keeps a close watch on Gautam Gambhir
a minute ago
Airbrush Brow Trend: Know Its Benefits, Procedure, And More
5 minutes ago
Federal Reserve interest rate decision
5 minutes ago
 Development is BJP's Main Agenda Says Kangana Ranaut As She Launches Campaign In Mandi
7 minutes ago
Dog walking tips
8 minutes ago
Vijay Varma
9 minutes ago
Bharat Rashtra Samithi (BRS) Rajya Sabha MP Keshava Rao is set to join the Congress party.
15 minutes ago
Pak PM Shehbaz Sharif Meets Country's Youngest Vlogger
17 minutes ago
Advertisement
Advertisement
Advertisement
Whatsapp logo